Plants with Oral Hypoglycaemic Action

References

• Wieland T H. Giftstoffe des grünen Knollenblatterpilzes (Amanitaphalloides). Helv. Chim. Acta 1961; 44: 919–926
   Web of Science ®Google Scholar
• Paris R., Moyse H. Matére Médicale, Vol I-III. Masson, Paris 1965–1971, 1965, 1969 and 1971
   Google Scholar
• Aharanson Z., Shani Mishinsky J., Sulman F. G. Hypoglycaemic effect of the Salt Bush (Atriplex halimus), a feeding source of the sandrat (Psammomys obesus). Diabetologia 1969; 5: 379–383
   PubMed Web of Science ®Google Scholar
• Shani J., Aharonson Z., Sulman F. G., Mertz W., Frenkel G., Kraicer P. F. Insulin potentiating effect of Salt Bush (Atriplex Halimus) ashes. Israel J. Med. Sci. 1972; 8(6)757
   PubMedGoogle Scholar
• Jordan E. O., Burrows W. The vomiting sickness of Jamaica B.W.I and its relation to akee poisoning. Amer. J. Hyg. 1937; 25: 520
   Google Scholar
• Evans K., Arnold L. Hypoglycin A and B. Trans. Roy. Soc. Trop. Med. Hyg. 1938; 32: 355
   Google Scholar
• Jelliffe D. B., Steuart K. L. Acute toxic hypoglycaemia in vomiting sickness of Jamaica. Brit. Med. J. 1954; 1: 75–77
   PubMedGoogle Scholar
• Hassal C. H., Reyle K., Feng P. Hypoglycin A and B: Biologically active polypeptides from Blighia sapida. Nature 1954; 173: 356–57, and Biochem. J. 60, 33
   Web of Science ®Google Scholar
• Hassal C. H. Blighia sapida. Manufact. Chem. 1955; 26: 494–496
   Google Scholar
• Chen K. K., Anderson R. C., Mc Gowen M. C., Harris P. N. Hypoglycaemic action of Hypoglycin A and B. Fed. Proc. 1955; 14: 326
   Google Scholar
• Leppla W., von Holt C. Blutzuckersenkende Peptide aus Blighia sapida. Naunyn-Schmied. Arch. Pharmakol. 1956; 228: 166
   Google Scholar
• Holt C. von, Leppla W. Untersuchungen fiber ein blutzuckersenkendes pflanz-liches Peptid. Bull. Soc. Chim. Belg. 1956; 65: 113–123
   Google Scholar
• Goldner M. G. Oral hypoglycemic agents past and present. Arch. Intern. Med 1958; 102: 830–840
   Google Scholar
• Feng P. C., Patrick S. J. Hypoglycine A. Brit. J. Pharmacol. 1958; 13: 125
   PubMed Web of Science ®Google Scholar
• von Holt C., von Holt L., Bohm H. Metabolic effects of hypoglycin and methylenecyclopropane-acetic acid. Biochim. Biophys. Acta 1966; 125: 11
   PubMedGoogle Scholar
• Sherrat H. S. A., Holland P. C., Marley J., Senior A. E. Mode of action of hypoglycin and related compounds Symp. Aldrige W.N. St. Martins, New York 1970; 205–218, Mech. Toxicity 1970
   Google Scholar
• Ashurstp R. Toxic substances of ackee. Review. J. Sci. Res. Counc. Jamaica. 1971; 2(1)4–16
   Google Scholar
• Brooks St. E. H., Andretsch J. J. Protective effects of feeding on the hepatic ultrastructure of rats treated with hypoglycin. J. Pathol. 1971; 104(3)167–174
   PubMed Web of Science ®Google Scholar
• West M. E., Hanley E. The isolation of 1-leucin-free hypoglycin A. J. Pharm. Pharmacol. 1968; 20: 974–975
   PubMed Web of Science ®Google Scholar
• West M. E., Sidrak G. H. Biological observations on hypoglycin A in the presence of leucine. W. Indian Med. J. 1970; 19: 19–24
   PubMedGoogle Scholar
• Persaud T. V. Effect of intraamniotic administration of hypoglycin B on foetal development in the rat. Exp. Pathol. 1972; 6: 55–58
   Google Scholar
• Holt C. von, Leppla W., Kroener B., von Holt L. Zur chemischen Kennzeichnung der Hypoglycine. Naturwissenschaften 1956; 43: 279
   Google Scholar
• Uciciani E, Defretin J. P., Boutoux M., Busson F. The proteins and lipids of Blighia sapida. Oléagineux 1964; 19: 18–19; 563–569
   Google Scholar
• Tanaka K., Isselbacher K. J., Shils U. Isovaleric and methylbutyric acidemias induced by hypoglycin A. Mechanism of vomiting sickness. Science 1972; 175(4017)69–71
   PubMed Web of Science ®Google Scholar
• Noble R. L., Beer and Cutts. Role of chance observation in chemotherapy, Vinca rosea. Ann. N. Y. Acad. Sci. 1958; 76: 882
   PubMed Web of Science ®Google Scholar
• Svoboda G. H., Gorman M., Root M. A. Alkaloids of Vinca rosea A preliminary report on hypoglycaemic activity. Lloydia 1964; 27(4)361–63
   Google Scholar
• Svoboda G. H. Alkaloids of Catharanthus roseus in cancer chemotherapy. Curr. Top. Plant. Sci. 1969; 303–305, 1969
   Google Scholar
• Guerra F. Acción del copalchi (Couteea latifolia) sobre la glucemia normal y la hiperglucemia diabética. Rev. Inst, de salubr. y enfermed. Trop. Mexico. 1947; 8: 29–38
   Google Scholar
• Paris R., Bastien M. PARIS and MOYSE, 2. vol. III. 1960; 377
   Google Scholar
• Paris R., Moyse H. Abrégé de Matière médicale. Vigot, Paris 1963
   Google Scholar
• Kirtikar K. R., Basu B. D. Ficus bengalensis. Indian Medicinal Plants 2nd ed. 1933, vol. II. 1053. vol. III. 2312. Allahabad
   Google Scholar
• Chopra R. N., Nayar S. L., Chopra I. C. Glossary of Indian Medicinal Plants. Counc. of Scientif. and Industr. Res, New Dehli 1956
   Google Scholar
• Jain S. R., Sharma S. N. Hypoglycaemic drugs of Indian indigenous origin. Planta Med. 1967; 15: 439–442
   PubMed Web of Science ®Google Scholar
• Jain R. C., Was C. R. Antidiabetic-like activity of onion extracts. Brit. med. J. 1974; 2: 730, 1974
   PubMed Web of Science ®Google Scholar
• Brahmachari H. D., Augusti K. T. Hypoglycaemic agents from Indian indigenous plants. J. Pharm. Pharmacol. 1961; 13: 381–382
   Web of Science ®Google Scholar
• Brahmachari H. D., Augusti K. T. Orally effective hypoglycaemic principles from Allium sativum, Ficus religiosa. J. Pharm. Pharmacol. 1962; 14: 254–255
   PubMed Web of Science ®Google Scholar
• Brahmachari H. D., Augusti K. T. Effects of orally effective agents from plants on alloxan diabetes. J. Pharm. Pharmacol. 1962; 14: 617
   PubMed Web of Science ®Google Scholar
• Gupta S. S., Jonathan I. S., Ahmad A. Experimental studies on pituitary diabetes. Effects of Ficus bengalensis and pituitary extract on glucose tolerance in rats. Indian J. Med. Res. 1966; 54(4)354–362
   Web of Science ®Google Scholar
• Vohora S. B. Antidiabetic studies on Ficus bengalensis L. Indian J. Pharm. 1970; 32: 68–70
   Google Scholar
• Ambike S. H., Rajarama Rao M. R. Studies on a phytosterolin from the bark of Ficus religiosa. Indian J. Pharm. 1967; 29: 91–92
   Google Scholar
• Varshney I. P., Bhatnagar S. P. Saponins and sapogenins from Indian Ficus species. Indian J. Pharm. 1965; 27: 235
   Google Scholar
• Modak A. T., Rajarama Rao M. R. Phytosterolin from Ficus religiosa. Indian J. Pharm. 1966; 28: 105
   Google Scholar
• Ritchie F., Calbraith N. M., Miller C. J., et al. Triterpenes from Ficus macrophylla. Colloq. Int. Centre Nat. Rech. Sri. Sydney 1966; 144: 107–111
   Google Scholar
• Collip J. B. Glucokinin a new hormone in plant tissue. J. Biol. Chem. Baltimore 1923; 56: 513–531
   Google Scholar
• Tanret G. Sur un alcaloide retiré du Galega officinalis L. X. C. R. Acad. Sci. Ser. D. 1914; 158: 1182
   Google Scholar
• Barger and White. Constitution of galeolutin. Biochem. J. 1923; 17: 827
   PubMedGoogle Scholar
• Müller H., Reinwein H. Zur Pharmakologie des Galegins. Naunyn Schmied. Arch. Pharmacol. 1927; 125: 212
   Google Scholar
• Reinwein H. Über die therapeutische Verwendbarkeit des Galegins bei Diabetikern. Münch. Med. Wochenschr. 1927; 74: 1794–95
   Google Scholar
• Simonnet H., Tanret G. Sur les propriétés hypoglycémiantes du sulfate de galégine. C. R. Acad. Sci. Ser. D. 1927; 184: 1600, and 185 1616
   Google Scholar
• Eliassow W. Über die Wirkung des Galegins bei Diabetes. Arch. Verdauungs-Krh. Berlin 1928; 42: 489–503
   Google Scholar
• Rathery F., Levina L. La galégine dans le diabète. Bull. Soc. Med. Hôp. Paris. 1928; 52: 1586–1594
   Google Scholar
• Parturier G., Hugonot G. Le galega dans le traitement du diabete. Presse Med. Paris 1935; 43(14)258–60, and LECLERC H. 1928. Le galéga (Galega officinalis L.). ibid. 36, 1634
   Google Scholar
• Golder W. Erfahrungen mit antidiabetischen Pflanzendrogen. Deut. Med. Wochenschr. 1939; 65: 804–805
   Google Scholar
• Lapinina O., Sisoeva T. F. Investigation of some plants to determine their sugar lowering action. Farmatsevt. Zh. 1964; 19(4)52–58, Chem. Abstr. 66, 1451 e
   PubMedGoogle Scholar
• Schreiber K., Pufahl K. Isolierung von (4)-Peganin aus der Geissraute (Galega officinalis L.). Arch. Pharm. 1964; 295: 271, and 295, 1962
   Web of Science ®Google Scholar
• Pufahl K., Schreiber K. Isolierung eines neuen Guanidin- derivates aus der Geissraute, Galega officinalis L. Experientia 1961; 17: 302–3
   PubMedGoogle Scholar
• Williams R. H. Diabetes. Hoeber, New York 1960; 480–509
   Google Scholar
• Falconer. Pharm. J. 1847; 7: 351
   Google Scholar
• Stoecklin W., Weiss E., Reichstein T. Gymnema sylvestre. Helv. Chim Acta 1967; 50(2)474
   Web of Science ®Google Scholar
• Kurihari Y. Antisweet activity of gymnemic acid Ai and its derivatives. Life Sci. 1969; 537–43, 1969
   PubMed Web of Science ®Google Scholar
• Trivadi. 1955, Thesis Agra University
   Google Scholar
• Mhaskar, Caius J. F. Gymnema sylvestre. Indian J. Med. Res. Mem. 1930; 16
   Google Scholar
• Stoecklin W. Gymnestrogin, ein neues Pentahydroxyterpen aus den Blattern von Gymnema sylvestre. Helv. Chim. Acta 1968–69; 51(6)1235–45, Structure, ibid. 52 (2), 365–70
   PubMedGoogle Scholar
• Cochran K., Maasab H. F. Inhibition of a cold variant of influenza virus by selected chemicals. Arch. Envir. Health 1970; 21(3)312–15
   PubMed Web of Science ®Google Scholar
• Sinsheimer J. E., Subba R. G., McIlhenny, et al. Constituents of Gymnema sylvestre leaves. V. Isolation and preliminary characterization of the gymnemic acids. J. Pharm. Sci. 1970; 59(5)622–28; 629–32, Isolation and antiviral activity of gymnemic acids. Experiantia 24, 302–3
   PubMed Web of Science ®Google Scholar
• Mitra P. P., Chakraborty, Ganguely T. Hypoglycaemic effect of indigenous drugs. Bull. Calcutta School Trop. Med. 1975; 23(1–4)6–7
   Google Scholar
• Rivera G. Preliminary chemical and pharmacological studies on “cundeamor” (Momordica charantia). Amer. J. Pharm. 1941; 113: 281, 114, 72–87, 1942
   Google Scholar
• Vad B. G. Place of Momordica charantia in the treatment of diabetes. Maharasthra Med. J. 1960; 6: 733
   Google Scholar
• Sharma V. N., Sogani R. K., Arora R. B. Some observations on the hypoglycaemic activity of Momordica charantia. Indian J. Med. Res. 1960; 48: 471
   Google Scholar
• Chatterjee K. P. On the presence of an antidiabetic principle in Momordica charantia. Indian J. Physiol. Pharmacol. 1963; 7: 240
   PubMedGoogle Scholar
• Gupta S. A., Seth C. S. Effect of Momordica charantia L. (karela) on glucose tolerance in albino rats. J. Indian Med. Ass. 1962; 39: 58
   Google Scholar
• Vohora S. B., Rizwan M., Khan J. A. Medicinal uses of common Indian vegetables. Planta Med. 1973; 23(4)381–393
   PubMed Web of Science ®Google Scholar
• Lotlikar M. M., Rajarama Rao M. R. Note on a hypoglycaemic principle isolated from the fruits of Momordica charantia L. J. Univ. Bombay 1960; 29: 223–224, 1966. Pharmacology of a hypoglycaemic principle isolated from the fruits of Momordica charantia L. Indian J. Pharm. 28, 129–133
   Google Scholar
• Kulkarni R. D., Gaitonde B. B. Potentation of tolbutamide action by jasad bhasma and karela (Momordica). Indian J. Med. Res. 1962; 50: 717
   Web of Science ®Google Scholar
• Sucrow W. Über Steringlucoside und ein neues Stigmastadienol aus Momordica charantia. Tethrahedron Lett. 1965; 26: 2217
   Google Scholar
• Olaniji A. A. A neutral constituent of Momordica foetida. Lloydia 1975; 38(4)361
   PubMedGoogle Scholar
• Olaniji A. A., Marquis V. O. Phytochemical and preliminary pharmacological investigation of the alkaloid contained in Momordica foetida. J. Pharmacy (Nigeria) 1975; 6: 117–119
   Google Scholar
• Colin J. Study on the antidiabetic prperties of Tecoma mollis and Observations on the antidiabetic properties of Cephalandra indica. J. Amer. Pharm. Ass. 1926–27; 15: 556–562, and 16, 190–203
   Google Scholar
• Garcia, Colin J. Study on the antidiabetic properties of Tecoma mollis. Prelimin. Rep. J. Amer. Pharm. Ass. 1926; 15: 556–60
   Google Scholar
• Guerra F. Farraacologia de plantas antidibeticas mexicanas. Acción de la tronadora (Tecoma mollis) en la glucemia normal y la hiperglucemia diabetica. Rev. Inst, salubr. y enfermed. Trop. Mexico 1946; 7: 213–220
   Google Scholar
• Nash J. B., Albers C. C., Howard J. K., Fly S. H., Jr. Lack of antidiabetogenic and antidiabetic effects on alloxan diabetes. Tex. Rep. Biol. Med. 1950; 8: E50
   Google Scholar
• Hammouda Y, Amer M. S. Antidiabetic effect of tecomine and tecostanine. J. Pharm. Sci. 1966; 55: 1452–1454
   Web of Science ®Google Scholar
• Jones G., Fales F. H. M., Wildman W. C. The structure of tecomamine. Tetrahedron Lett. 1963; 397–401
   Google Scholar
• Hammouda Y, Motawi. Alkaloids and triterpenes of Tecoma stans. Proc. Pharm. Soc. Egypt. 1959; 16: 73–179
   Google Scholar
• Hammouda Y., Plat M. M., Le Men J. Un nouvel alcaloide du Tecoma stans: la tecostanine. Ann Pharm. Fr. 1963; 21: 699–702
   PubMedGoogle Scholar
• Hammouda Y., Rashid A., Amer M. S. Hypoglycaemic properties of tecomine and tecostanine. J. Pharm. Pharmacol. 1964; 16: 833–34
   PubMed Web of Science ®Google Scholar
• Hammouda Y., Khallafallah N. Stability of tecomine, the major antidiabetic factor of Tecoma stans. Juss. J. Pharm. Sci. 1971; 60: 1142–1145
   PubMed Web of Science ®Google Scholar
• Fournier F. Plantes medicinales et veneneuses de France, vol. III. 1948; 495, Paris 1948
   Google Scholar
• Sulman F. G., Menczel E. Antidiabetic plant products: Extracts of Eragrostis bipinnata, Opuntia ficus-indica, O. vulgaris, Teucrium polium, Trigonella foenum-graecum, Zea styles. Harokeach Haivre 1962; 9: 6–26, Chem. Abstr. 57, 11–11308c)
   Google Scholar
• Menczel E., Mishinsky J., Sulman F. G. Trigonelline in hyperglycaemia. Proc. Isr. Psysiol. Pharmacol. Soc. 1965; 1: 47
   Google Scholar
• Mishinsky J., Joseph B., Sulman F. G., Goldschmied A. Hypoglycaemic effect of trigonelline. Lancet 1967; 1311–12, 1967
   Web of Science ®Google Scholar
• Shani J. A., Goldschmied Joseph B., Ahronson Z., Sulman F. G. Hypoglycaemic effect of Trigonella foenum-graecum, Lupinus terminis seeds and their major alkaloids in alloxan diabetic and normal rats. Arch. Int. Pharmacodyn. Ther. 1974; 210: 27
   PubMedGoogle Scholar
• Varsney I. P., Sharma S. C. Saponins and sapogenins XXXII. Trigonella foenumgraecum seeds. J. Indian Chem. Soc. 1968; 43(8)564–567
   Google Scholar
• Hardman R., Fazli F. R. Y. Steroid sapogenins from Trigonella foenumgraecum. Planta Med. 1972; 21: 131, 188, 322
   PubMedGoogle Scholar
• Ketlik. Myrtillus an antidote in diabetes mellitus. Pester Med. Chir. Presse 1893; 29: 633
   Google Scholar
• Steinegger E., Hänsel R. Lehrbuch der allgemeinen Pharmacognosie. Springer, Heidelberg 1963, 1973 1963. New Ed. 1973
   Google Scholar
• Allen F. M. Blueberry leaf extract. Can. Med. Ass. J. 1927; 1539–40, 1927
   PubMedGoogle Scholar
• Allen F. M. Blueberry leaf extract: Physiologic and clinical properties in relation to carbohydrate metabolism. J. Amer. Med. Ass. 1927a; 89: 1577
   Google Scholar
• Rathery F., Levina L. Myrtille et diabète. Bull. Soc. Med. Hôp. Paris 1928; 52: 1758–1764
   Google Scholar
• Edgars N. K. The blueberry. Pharmacology of neomyrtillin from blueberry leaf with a description of Vaccinium caesarense and complete analysis of leaf and fruit. Pharm. Diss. N. York Coll. Pharm. 1929
   Google Scholar
• Wilder R. M., Allen F. M. Synthalin, blueberry leaf extract and glukhorment. Trans. Pract. Amer. Med. Ass. 1928; 38: 254–268
   Google Scholar
• Willstätter, Zollinger. Farbstoffe der Weinraute und der Heidelbeere. Der Heidelbeerfarbstoff. Gewinnung des Myrtillinchlorides. Ann. Chem. 1925; 408: 103–109, 412, 204
   Google Scholar
• Karrer P., Widmer. Myrtillin. Helv. Chim. Acta 1927; 10: 5
   Google Scholar
• Mc Ilroy. The Plant Glycosides. Arnold, London 1951
   Google Scholar
• Pourrat H., Tronche P., Pourrat A. Nouveau précedé d'extraction des glycosides d'anthocyanes. Bull. Soc. Chim. Fr. 1966; 1918–20, 1966
   PubMedGoogle Scholar
• Pourrat H. Drogues à Anthocyanes et maladies vasculaires. 1977, Plantes médicinales et phytotherapie XI n. spec. 143–151
   Google Scholar
• Pourrat H., Guichard J. P., Pourrat A., Malmaison J. L. Anthocyanes et flavones des feuilles de Vaccinium corymbosum L PI. Med. et Phytother. 1978; 12(3)212–216
   Google Scholar
• Tryon A. F. Ferns of the Inca. Amer. Fern. J. 1959; 49: 10–24
   Google Scholar
• Laurens A., Paris R. Sur les polyphenols d'Anacardiacées Africaines et Malgaches; Poupartia spp. et Anacardium occidentale. Mat. Med. et Phytothér. XI 1976; 1: 16–24
   Google Scholar
• Janot M. M., Laurin J. Action hypoglycémiante des bulbes d'Allium cepa L. C.R. Acad. Sci. Sect D. 1930; 191: 1098–99
   Google Scholar
• Laurin J. Action hypoglycémiante des bulbes d'Allium cepa L. C.R. Acad. Sci. 1931; 192: 1289–91
   Google Scholar
• Laland P., Havrevold O. W. Zur Kenntnis des per os wirksamen blut-zuckersenkenden Prinzips der Zwiebeln. Hoppe Seylers. Z. Physiol. Chem. 1933; 221: 180–96
   Google Scholar
• Kreitmar H. Pharmakologische Versuche mit eigenen einheimischen Pflanzen. Mercks Jahresber. 1936; 50: 102–110
   Google Scholar
• Bhandari P. R., Mukerje B. Garlic (Allium sativum) and its medicinal values. Nagarjun, India 1959; 121
   Google Scholar
• Brahmacharim D., Augusti K. T. Orally effective hypoglycaemic agents from plants. Orally effective principle from Allium cepa. J. Pharm. Pharmacol. 1961; 13: 128
   Google Scholar
• Sinha A., Sanyal A. K. Separation and estimation of sugar component of Allium cepa L. by paper chromatography. Curr. Sci. India 1959; 28: 281
   Google Scholar
• , Augusti and coworkers 1974, 1975, 1976. Series of publications on identification of onion principles and their effects on blood glucose, free fatty acid and insulin levels, and glucose tolerance in animals and men
   Google Scholar
• Augusti K. T., Benaim M. E. Effect of essential oil of onion (allylpropyldisulphide) on blood glucose, free fatty acid and insulin levels of normal subjects. Clin Chim. Acta 1974; 60: 121–123
   Web of Science ®Google Scholar
• Augusti K. T., Roy V. C. M., Semple M. Effect of allyl propyl disulphide isolated from onion (Allium cepa L.) on glucose tolerance of alloxan diabetic rabbits. Experientia 1975; 30: 119
   Google Scholar
• Matthew P. T., Augusti K. T. Hypoglycaemic effects of onion on diabetes mellites. Indian J. Physiol, and Pharmacol. 1975; 19(4)213–217
   PubMedGoogle Scholar
• Augusti K. T. Studies on the effect of allicin (diallyl disulphide oxide) on alloxan diabetes. Experienta 1975; 30: 119
   Google Scholar
• Augusti K. T. Gas chromatographic analysis of onion principles and a study of their hypoglycaemic action. Indian J. Exp. Biol. 1976; 14(2)110–112
   PubMedGoogle Scholar
• Augusti K. T. Chromatographic identification of certain sulphoxides of cysteine present in onion (Allium cepa L). Curr. Sci. 1976; 45(24)863–4
   Web of Science ®Google Scholar
• Hermann K. Allium cepa L. Flavonoiden. Naturwissenschaften 1956–58; 43: 158, and Arch. Pharm. 291, 238 (1958)
   Google Scholar
• Kazmarek, et al. Flavonoides d'Allium cepa. Biul. Inst. Róslm Leczniczyk 1961; 7: 157, in Hegnauer Vol. II
   Google Scholar
• Silver A. A., Krantz J. C. Effect of ingestion of burdock root on normal and diabetic individuals. Premil. Rep. Ann. Int. Med. Ann. Arbor 1931; 5: 274–284
   Google Scholar
• Schulte K. E., Rucker G., Boehmer G. Polyacetylene als Inhaltstoffe der Klettenwurzel. Arzneimittelforschung 1967; 17: 829–833
   PubMedGoogle Scholar
• Suchy M., Horak M., Herout V., Sorm F. Structure of arctiopicrin sesquiterpene lactone from Arctium minus. Croat Chem. Acta 1957; 29: 247–54, Chem Abstr. 53, 16197, and 22062a
   Google Scholar
• Omaki. Arctiin a constituent of the seeds of Arctium lappa L. I. J. Pharm. Soc. Jap. 1935; 55: 816–27, ibid. 56, 982–85
   Google Scholar
• The position of the hydroxyl group of arctigenin. J. Pharm. Soc. Jap., 57: 22–25; 269–74
   Google Scholar
• Ha Worth R. D., Kelly W. The constituents of natural phenolic resins VII. Arctigenin. J. Chem Soc. commun. 1936; 998–1003, 1936
   Google Scholar
• Corter K. Polyphenole und phenolische Heterosiden in Pflanzen. Arch. Pharm. 1909; 247: 184
   Google Scholar
• Bate Smith. Plants and taxonomic constituents I. Dicotyledons, The phenolic constituents. J. Linn. Soc. London 1962; 58: 95–173
   Google Scholar
• Miller M. D. Argyrea nervosa, a tropical woodrose. J. Ass. Offic. Anal. Chem. 1970; 53(1)123–7, Chem. Abstr. 72, 75644h
   Google Scholar
• Denber H. C. B. Neuropsychopharmacology vol II, E. Rothlin. Elsevier, Amsterdam 1961; 25
   Google Scholar
• Shikinami Y. Über die Hypoglykaemie erzeugenden Stoffe aus Pflanzen und Mikroorganismen. (Aspergillus oryzae). Yohoku J. exp. Med. 1928; 10: 560
   Google Scholar
• Lewis J. J. Diabetes and the Insulin-administration problem. Physiol. Rev. 1949; 29: 75–90
   PubMed Web of Science ®Google Scholar
• Helmreich E. Tierexperimentelle Untersuchungen über einen blutzuckersenkenden, oral wirksamen Stoff aus Aspergillus niger Klin. Wochenschr. 1951; 29: 375–377
   PubMedGoogle Scholar
• McMillan. Tropical Planting and Gardening, Sect. IV. Medicinal Pl. MacMillan, London 1954
   Google Scholar
• , Martindale. The Extra Pharmacopoeia 1958. Asteracantha p. 1359. XXLVth Ed., Pharm. Press London
   Google Scholar
• Späth E., Kestler-Gandini F. Über ein Nebelalkaloid aus Adhatoda vasica Nees (Acanthaceae). Monatsh. Chem. 1960; 91: 1150
   Google Scholar
• Basu D. K., Rakhit S. Chemical investigation of Hygrophila spinosa. Indian J. Pharm. 1957; 19: 205, 282, 285
   Google Scholar
• Govidachari T. R., et al. Asteracantha longifolia constituents. J. Sci. Ind. Res. India 1957; 16b: 72
   Google Scholar
• ANON. Mededeelingen 'Lands Plantentuin. 137, Batavia, 1897, 74, 1899
   Google Scholar
• Lagawankar J. D., Phalnikar N. L., Bhide B. V. Chemical investigation of Hygrophila spinosa. J. Univ. Bombay 1945; 13: 515–17, Chem. Abstr. 1945, 4191
   Google Scholar
• Chatterjee A., Shrimani S. K. Isolation of lupeol from Asteracantha longifolia Nees. J. Ind. Chem. Soc. 1957; 34: 882–84
   Google Scholar
• Dubin H. R., Corbitt H. B. Isolation of a hypoglycaemia producing principle from vegetables and nature of action of vegetable extracts on bloodsugar of normal rabbits J. Metab. Res. 1923; 4: 89
   Google Scholar
• Ederer S. Beeinflussung des Blutzuckers durch einen peroral wirksamen Pflanzenextract. Klin. Wochenschr. 1927; 6: 72
   Google Scholar
• Macdonald A. D., Wislicki L. Effect of cabbage extracts on carbohydrate metabolism. J. Physiol. London. 1938; 94: 249
   Google Scholar
• Johnson A. E., Nursten H. E., Williams A. A. Organic disulphides in plants Chemistry and Industry. 1971, 1971 1. 556
   Google Scholar
• Macdonald A. D. Addendum to 131. Brit. J. Pharmacol. 1956; 5: 24
   Google Scholar
• Lewis J. J. Cabbage extracts and insulin-like activity. Brit. Pharmacol. 1950; 5: 21–24
   PubMed Web of Science ®Google Scholar
• Bigarra B., Labo B., Ma J. V., Puig A. C., Yufera E. P. Hypoglycaemic effect of Centaurea species. Farmacognosia 1950; 10: 197
   PubMedGoogle Scholar
• Labo B., Ma J. V., Puig A. C. Hypoglycemic effect of Centaurea aspera. Farmacognosia 1953; 13: 223
   PubMedGoogle Scholar
• Viguera J. M., Casabuera A. Hypoglycemic activity in the genus Centaurea VI. Fractionation of the active peptides by ammonium sulfate. Farmacognosia Madrid 1965; 25: 89–102
   PubMedGoogle Scholar
• Ahmed Z. F., Hammouda F. M., Rizk A. M., Ismail S. I. Phytochemical studies of certain Centaurea species. Planta Med. 1971; 19: 264–269, and 18, 227–231
   PubMed Web of Science ®Google Scholar
• Kamanzi K., Raynaud J. Contribution à l'étude des glucosides flavoniques de Centaurea solstitialis L. Plant Med. Phytothér. 1976; 10(2)78–84
   Google Scholar
• Monya M., Racz G. Recherches concernant le contenu en flavonosides de certaines espèces du genre Centaurea L. Recherches chromatographiques. PI. Med. Et Phytother. 1974; VIII(2)126–33
   Google Scholar
• Chopra R. N., Bose J. P. Cephalandra indica (telacucha) in diabetes. Indian J. Med. Res. 1925; 13: 125–126
   Google Scholar
• Observations on the anti-diabetic properties of Cephalandra indica (telekucha). Indian Med. Gaz., 60: 201–202
   PubMedGoogle Scholar
• Mukerje B. 1953, Indian Pharm. Codex Vol. I p. 127 New Dehli
   Google Scholar
• Brahmachari M. D., Augusti K. T. Orally effective hypoglycaemic principles from Coccinia indica. J. Pharm. Pharmacol. 1963; 15(6)411
   PubMed Web of Science ®Google Scholar
• Mukerjee K., Ghosh N. C. Coccinia indica as potential hypoglycaemic agent. Indian J. Exper. Biol. 1972; 10(5)347–349
   PubMed Web of Science ®Google Scholar
• Barber C. A. Flavonoids of staminate and pistillate squashflowers. Arch. Biochem. Biophys. 1956; 64: 401–411
   PubMed Web of Science ®Google Scholar
• Dannil P. M., Fowden L. γL glutamyl peptide from cucumberseeds. Biochem. J. 1963; 86: 388
   PubMed Web of Science ®Google Scholar
• Noe F. F., Fowden L. β-pyrazol 1-ylalanine an amino acid from watermelon seeds (Citrullus vulgaris). Biochem J. 1960; 77: 543
   PubMed Web of Science ®Google Scholar
• Uzan M., Dziri A. Influence sur le metabolisme glucidique d'un extrait des feuilles de Corchorus olitorius. Sem. Hop. Paris 1952; 28: 2532
   PubMedGoogle Scholar
• Peters G. Insulinersatzmittel pflanzlichen Ursprungs. Deut. Med. Wochenschr. 1957; 82: 320–322
   PubMedGoogle Scholar
• Frerejacque M., Durgat M. Poisons digitaliques de graines de jute. C. R. Acad. Sci. 1954; 238: 507
   Google Scholar
• Csutak V., Cuparencu B., Madar J. Influence of certain cardiotonic glucosides and antiarrhythmic drugs on radioactive phosphate incorporation, ascorbic acid level and glycaemia in the rat. Through Chem. Abstr. 1972; 76, 10288h
   Google Scholar
• Large R. G., Brocklesby C. N. Hypoglycaemic substance from roots of Devil's club (Fatsia horrida). Can. Med. Ass. J. 1938; 39: 32
   PubMedGoogle Scholar
• Page I. H. The influence of diet on the alkaline reserve and insulin hypoglycaemia in rabbits. Amer. J. Physiol. 1923; 66: 1
   Google Scholar
• Smolenski J, Silinis H., Farnsworth N. R. Alkaloid screening. Lloydia 1972; 35: 1–34
   PubMedGoogle Scholar
• Ramond F. New hypoglycaemic agent. Abstract. J. Amer. Med. Ass. 1957; 164: 85
   Google Scholar
• Donard E., Labbe H. Sur les proprietes hypoglycemiques de principes extraits de radicelles d'orge. C. R. Acad. Sci. Paris Ser. D 1930–33; 194: 1299, and ibid.; 96, 1047
   Google Scholar
• Donard E., Labbe H. Sur les proprietes hypoglycemiantes du maltose et de la mannite contenus dans les extraits de radicelles d'orge avant et apres la fermentation. C.R. Soc. Biol. 1933; 112: 1675
   Google Scholar
• Labbe M. The vegetable insulinoides and their therapeutic indications. Can. Med. Ass. J. 1936; 34: 141–144
   PubMedGoogle Scholar
• Garcia. Distribution and deterioration of the insulin-like principle in Lagerstroemia speciosa. Acta Med. Philipp. 1941; 3: 99, Chem. Abstr. 1942, 560
   Google Scholar
• Sharaf A., Mansour M. Y. Pharmacological studies on the leaves of Morus alba, with special reference to its hypoglycemic activity. Planta Med. 1964; 12: 71–72
   Google Scholar
• Hegnauer R. Chemotaxonomie der Pflanzen. Vol. I-V. Birkhauser, Basel/Stuttgart 1962–1969
   Google Scholar
• Bergman E. O., Ikan R., Harel S. Thin layer chromatography of β-sitosteryl esters. J. Chromatogr. 1964; 15: 204, in 157. vol. V
   PubMed Web of Science ®Google Scholar
• Talyshinski G. M. Formation of rutin in leaves of mulberry trees. Dokl. Akad. Nauk. Azerb. 1967; 23(1)63–6, Chem. Abstr. 67, 71091z
   Google Scholar
• Naito K. Moracetin from the leaves of the mulberry tree. Agr. Biol. Chem. Tokyo 1968; 32: 33a
   Google Scholar
• Paris R., et al. Morus mesozygia Stapf. Ann. Pharm. Fr. 1966; 24: 745
   PubMed Web of Science ®Google Scholar
• Deshpande V. H., et al. Four analogues of artocarpin and cycloartocarpin from Morus alba. Tetrahedron Lett. 1968; 1715, 1968
   Web of Science ®Google Scholar
• Leclerc H. Action hypoglycémiante de la feuille du murier noir (Morus nigra L.). Presse Méd. 1934; 42: 1522
   Google Scholar
• Jain S. R. Musa sapientum. Planta Med. 1968; 16: 43–47
   PubMed Web of Science ®Google Scholar
• Hood A. M., Lowburry E. J. L. Anthocyanins in bananas. Nature (London) 1954; 173: 402–403
   Web of Science ®Google Scholar
• Sinha, et al. 5-Hydroxytryptamine in bananas. Biol. Abstr. 1962; 39: 16587
   Google Scholar
• Luthy N., Martinex Fortun O. A possible oral hypoglycemic factor in Ocimum sanctum Ohio. J. Sci. 1964; 64: 223–4, Chem. Abstr. 61, 4860d
   Google Scholar
• Ingram W. W., Rud G. V. Influence of extracts of Prickly pear on diabetes mellitus. Med. J. Australia 1930; 2: 360–63
   Google Scholar
• Esdorni. Die Ginsengwurzel auf dem heutigen Drogenmarkt. Pharmazie 1960; 15: 75–81, and ibid. 13, 356
   PubMedGoogle Scholar
• Petkow W. Pharmakologische Untersuchungen über den Wirkungsmechanismus der Droge Panax ginseng G. A. Mey. Arzneimittelforschung 1961; 9: 305–311, ibid. 11, 288–295, and 419–422
   Google Scholar
• Kim Chul, Kim C. C., Kim M. S., et al. Influence of ginseng on the stress mechanism. Lloydia 1970; 33(1)43–48
   PubMedGoogle Scholar
• Shibata S., et al. The structure of panaxodiol a sapogenin of Ginseng. Tetrahedron Lett. 1962; 10: 419–422
   Google Scholar
• Elyakov G. B., et al. Glycosides from Ginseng roots. Tetrahedron Lett. 1964; 48: 3591–97
   Google Scholar
• Elyakov G. B., et al. The probable structure of the true aglycones of Ginseng glycosides. Tetrahedron Lett. 1968; 24: 5483–91
   Google Scholar
• Brekhman I. E., Ardymon I. V. D. Pharmacological investigation of glycosides from Ginseng and Eleuthrococcus. Lloydia 1969; 32(1)46
   PubMedGoogle Scholar
• Eisler M., Portheim L. Ueber insulinartige Stoffe aus Bohnen und deren Wirkung auf den Kohlehydratstoffwechsel. Biochem. Z. 1924; 148: 566
   Google Scholar
• Kaufman E. Insulinartige Pflanzenextrakte. Die Behandlung des Diabetes mit Bohnenschalentee. Ber. Ges. Physiol. 1927; 38: 151, Z. exp. Med. Berlin 55, 1–12
   Google Scholar
• Gessner O., Siebert K. Über die blutzuckersenkende Wirkung von Phaseoluspräparaten. Münch. Med. Wochenschr. 1928; 20: 853–54
   Google Scholar
• Gebhardt F. Über Phaseolan. Z. exper. Med. Berlin 1930; 70: 397–402
   Google Scholar
• Hartleb. Experimentelle und klinische Untersuchungen zur Frage der peroralen Diabetes behandlung mit insulinahnlichen pflanzlichen Stoffen (Phaseolan). Münch. Med. Wochenschr. 1932; 1795–99, 1932
   Google Scholar
• Lyass M. A., Vovsi V. L. Kidneybean extract with properties similar to insulin for therapy of diabetes. Sov. Klin. 1932; 17: 240–3
   Google Scholar
• Sachser J. A. An IAA oxidase inhibitor system in bean pods. Amer. J. Bot. 1961; 48: 820
   Web of Science ®Google Scholar
• Langecker H. Über die blutzuckerherabsetzende Wirkung von Rhizoma polygonata einer antidiabetischen Volksdroge. Bioch. Z. Berlin 1930; 222: 173–190
   Google Scholar
• Hegnauer R. Vorkommen von Cardenolide. Planta Med. 1970; 19: 139–153
   Google Scholar
• Steinmetz E. Poterium spinosi Cortex radice: Neues Mittel gegen Diabetes. Quart. J. Crude Drug. Res. 1964; IV(3)582–588, Experientia 20 (2), 78–79
   Google Scholar
• Schlütz G. O., Venulet J. Poterium spinosum und sein Einfluss auf den Blutzuckergehalt von Kaninchen. Experientia 1964; 20(2)78–79
   PubMedGoogle Scholar
• Mishinsky J., Menczel E., Sulman F. G. Hypoglycemic effect of Poterium spinosum. Arch. Int. Pharmacodyn. Ther. 1966; 161(2)306–13
   PubMedGoogle Scholar
• Pourrat A., Pourrat H. Poterium spinosum. Bull. Soc. Chim. 1961; 884, 1961 1962, 1963 ibid. 1962, 694; Ann. Pharm franc. 21, 55
   Google Scholar
• Potier P., Das B. C., Bui A. M., et al. Poterium spinosum. Bull. Soc. Chim 1966; 3458–3465, 1966
   Google Scholar
• Pourrat A., Pourrat H., Potier P. Poterium spinosum Tormentoside and sitosterol, possible hypoglycaemic root constituents. Ann. Pharm. franc. 1973; 31: 321–324
   PubMedGoogle Scholar
• Baisset A., Foulhoux P., Montastruc P. Effects of a polyflavan on experimental hypertension in dogs. Therapie 1976; 31: 659–665
   PubMed Web of Science ®Google Scholar
• Shani J., Joseph B., Sulman F. G. Fluctuation in the hypoglycaemic effect of Poterium spinosum. Arch. Int. Pharmacodyn. Ther. 1970; 185(2)344–349
   PubMedGoogle Scholar
• Mirsky I. A., Diengott G., Perisutti G. Hypoglycaemic and insulinase inhibitory action of some plant growth regulators. Endocrinology 1956; 59: 715–18
   PubMed Web of Science ®Google Scholar
• Quisenberg T. H., Gjerstad G. Poterium spinosum a potential cure for diabetes. Quart. J. Crude Drug Res. 1967; VII(1)957–64
   Google Scholar
• von Euler U. Ein insulinartiger Korper in der Hefe. Biochem. Z. 1928; 194: 197
   Google Scholar
• Nath M. C. Investigations on a new antidiabetic principle (amellin) occuring in nature; studies on some of its biochemical properties. Ann. Biochem. exp. Med. Calcutta 1943; 3: 55–62
   Google Scholar
• Nath M. C., Banerjee S. R. Amellin; its effect on glycosuria and hyperglycaemia in cases of human diabetes. Ann. Biochem. exp. Med. Calcutta 1943a; 3: 63–84
   Google Scholar
• Nath M. C., Chakravorty M. K., Bannerjee S. R. Amellin; Its influence in increasing haematopoietic activity in diabetes. Ann. Biochem. exp. Med. Calcutta 1943b; 3: 107–120
   Google Scholar
• Nath M. C., Chowdurry N. K. Its effect on utilization of inorganic phosphate in blood of diabetics. Ann. Biochem. exp. Med. Calcutta 1943c; 3: 121–130, and its influence in causing relief in hypercholesterolemia 3, 147–156
   Google Scholar
• Kath M. C., Chowdurry. Its role in prevention of excessive protein catabolism in diabetes. Ann. Biochem. exp. Med. Calcutta 1945; 5: 11–16
   Google Scholar
• Nath M. C., Chakravorty M. K., Brahmachari M. D. Its role in reduction of acetone bodies and increase of alkali reserve of blood nitrogen of diabetics. Ann. Biochem. exp. Med. Calcutta 1945a; 5: 101–104
   PubMedGoogle Scholar
• Whittacker H. Amellin for diabetes. Brit. Med. J. 1948; 1: 546–47
   PubMedGoogle Scholar
• Chatterjee M. S., Roy D. Pharmacological studies of the seeds of Securinega securidaca Effect on normal blood sugar of cat and rabbit. Bull. Calcutta School Trop. Med. 1965; 13(1)12–14
   PubMedGoogle Scholar
• Iketobosin G. D., Mathieson D. W. The isolation of hordenine and norsecurinine from Securinega virosa Baill. J. Pharm. Pharmacol. 1963; 15: 810
   PubMed Web of Science ®Google Scholar
• Chatterjee A., et al. Securinega alkaloids. Allosecurinine in Indian Securinega species. J. Indian Chem. Soc. 1964; 41: 163
   Google Scholar
• Satoda, et al. Studies on securinine and allosecurinine. Tetrahedron Lett. 1962; 1199–1202, 1962
   Web of Science ®Google Scholar
• Heric Z., et al. Alkaloids of Securinega species. Chem. Pharm. Bull. Tokyo 1964; 12: 1118
   PubMedGoogle Scholar
• Saito S., Tanaka T., et al. Determination of securinine and its stereoisomers in plants of the Securinega species and isolation of viroallosecurinine and virosine. J. Pharm. Soc. Japan 1964; 84, MX2Y-EE
   Google Scholar
• Saito, et al. Structure and stereochemistry of norsecurinine and dihydrosecurinine. Chem. Pharm. Bull. Tokyo 1964a; 12: 1520
   PubMed Web of Science ®Google Scholar
• Anjaneyulu, et al. Alkaloids of Securinega leucopyrus. Indian J. Chem. 1965; 3: 237
   Google Scholar
• Kjaer A., Friis P. Isothiocyanates from Putranjeva Roxburghii Wall, including S. 2-methylbutyl isothiocyanate a new mustard oil of natural derivation. Acta Chem. Scand. 1962; 16: 936–946
   Google Scholar
• Puntambekar S. V. Glucosides of Putranjeva Roxburghii Wall. (Securinega). Proc. Indian Ac. Sci. 1950; 32A: 114
   Google Scholar
• Plouvier V. Sur la présence de rutine dans les feuilles de Securinega. C. R. Acad. Sci. 1963; 257: 4061
   Google Scholar
• Kaufman E. Hypoglykämische Wirkung von Eugenia jambolana Lam. Z. Ges. Exp. Med. 1928; 62: 147–159; 739–744
   Google Scholar
• Hart M. C., Heyl F. W. Some constituents of jambul. J. Amer. Chem. Soc. 1916; 2805, 1916
   Google Scholar
• Mercier F., Bonnafous. Action hypoglycemiante (d'Eugenia jambolana. C. R. Soc. Biol. Paris 1940; 133: 150
   Google Scholar
• Nadkarni K. M. The Indian Materia Medica 3rd Ed. 1954, Bombay
   Google Scholar
• Sepaha G. C., Bose S. N. Clinical observations on the antidiabetic properties of Pterocarpus marsupium, Eugenia jambolana. J. Indian Med. Ass. 1956; 27: 388
   PubMedGoogle Scholar
• Chem Abstr. 1972; 158336t, Laroche Navaron Patent 1968
   Google Scholar
• Venkateswarlu G. J. Cyanidine rhamnoglucosides in Eugenia jambolana. Ind. Chem. Soc. 1952; 29: 435
   Web of Science ®Google Scholar
• Sigognau-Jagodzinski M., Bibal-Prot P., Chanez M., Boiteau P., Ratsimamanga Rakato. Eugenia jambolana. C. R. Acad. Sci. 1966; 264(8)1119–23
   Google Scholar
• Nair A. G. R., Subramanian S. Eugenia triterpene A and Eugenia triterpene B in Eugenia jambolana. J. Sc. Ind. Res. India 1962; 21B: 457
   Google Scholar
• Balansard J. Sur quelques Labiés à lactone. C. R. Soc. Biol. 1934; 117: 1014
   Google Scholar
• Fikenscher L. H., Hegnauer R. Sur les hétérosides iridoides du genre Teucrium. Planta. Med. Phytother. 1969; 3(3)183, and Planta Med. Suppl. 1966, 117–118
   Google Scholar
• Lallemant-Guilbert, Bezanger Beauquesne L. Recherches sur les flavonoides de quelques Labiés médicinales. Pl. Med. Phytotherapie 1970; 4: 92–107
   Google Scholar
• Namjoshi A. N. Studies on the pharmacognosy of Tinospora cordidolia Miers. Bull. Nat. Inst. Sci. India 1955; 4, Proc. 113–17
   Google Scholar
• Raghunathan K., Sharma P. V. Effect of Tinospora cordifolia Miers on alloxan-induced hyperglycaemia. J. Res. Ind. Med. India 1967; 32: 203–209
   Google Scholar
• Gupta S. S., Valadars J. R. E., Gorg V. P., Mahesh R. Further observations on the antidiabetic effects of Tinospora cordifolia, Caesarea esculenta. Indian J. Physiol. Pharmacol. 1967; 11–12, 1967
   Google Scholar
• Mehra P. N., Puri H. S. Studies on Gaduchi sativa (Tinospora). Indian J. Pharm. 1969; 31(6)180
   Google Scholar
• Beauquesne L. Tinospora bakis. Thesis, Pharm., Paris 1937
   Google Scholar
• Paris R., Beauquesne L. Tinospora cordifolia. Bull. Soc. Pharm. Er. 1939; 46: 73–76, and 45, 7
   Google Scholar
• Marx A. V., Adler E. Über die blutzuckerherabsetzende Wirkung von Herba Urticae dioicae. Naunyn-Schmied. Arch. Pharmakol. 1926; 112: 29–38; 56
   Google Scholar
• Flueck H. Nos plantes médicinales. 1942, Ed. Ott, Thun p. 24
   Google Scholar
• Turner C. T., Craig. Hypoglycaemic Compositae. Chem. Abstr. 1975; 84: 184884c
   Google Scholar
• Gnadt A. 1946, Blutzuckersenkende Wirkung von Zea Mays Pharmazie 1946, 103
   Google Scholar
• Menczel E, Sulman F. G. Hypoglycaemic effect of Zea styles. Proc. Soc. Exp. Biol. Med. 1962; 110: 178–181
   PubMed Web of Science ®Google Scholar
• Repke D. B., Mandell D. M., Thomas J. D. Alkaloids of Acacia baileyana. Lloydia 1973; 36(2)211–213
   PubMedGoogle Scholar
• Singh K. N., Chandra V., Barthwal K. C. Hypoglaemic activity of Acacia arabica, A. benthami & A. modesta; leguminous seed diets in normal young albino rats. Ind. J. Physol. & Pharmacol. 1975; 19(3)167–8
   PubMedGoogle Scholar
• Johns S. R., Lamberton J. A., Sicrumis A. A. Alkaloids of Actinodaphne nitida. Aust. J. Chem. 1969; 22(10)2257
   Web of Science ®Google Scholar
• Krishna S., Chose T. P. Actinodaphnine from the bark of Actinodaphne hookeri. J. Indian Chem. Soc. 1932; 9: 429–33
   Google Scholar
• Ghose T. P., Krishna S., Schlittler E. Constitution of actinodaphnine. Helv. Chim. Acta. 1934; 17: 919–30
   Google Scholar
• De Vera C. R., Mesa S. P., Diego A. M., Del Fresno A. U. Preliminary Study of the Effect of vulgarin (a new natural hypoglycaemic agent) on the lipid level of several organs of the rat. Boll. Chim. Farm. 1976; 115: 445–456
   PubMedGoogle Scholar
• Hug E., Vila C., Minhaar T. C. Sobre la pretendida acción antidiabética de la Bauhinia candicans (pezuna di vacca). Rev. Med. Rosario 1939; 29: 1277–1285
   Google Scholar
• Bandoni A. L., Mendiondo M. E., Rondina R. V. D., Coussic J. D. Survey of Argentine medicinal plants. Phytochemical screening. Lloydia 1972; 35(1)69–80
   PubMedGoogle Scholar
• Williman J. J., Schubert B. C. Alkaloid bearing plants and their contained alkaloids U. S. Dept. Agric. A. R. S. Bull. 1961; 1234
   Google Scholar
• Williman J. J., Hui Lin L. Alkaloid bearing plants and their contained alkaloids 1957–68. Lloydia 1970; 33(3a), suppl
   Google Scholar
• Pellizoni F. Diterpenoids (from Caesalpinia bonducella etc). Corsi Semin. Chim. 1968; 11: 53–56, Chem. Abstr. 72, 21749
   Google Scholar
• Greshoff M. Mitteilungen aus dem chemisch pharmakologischen Laboratorium des botanischen Gartens zu Buitenzorg. Ber. Deut. Chem. Ges. 1890; 1890: 3537–3550
   Google Scholar
• Robert A, Duquénois P. Utilisation des Cassias des pays tropicaux et subtropicaux. Examen des constituants chimiques. Plant. Med. Phytother. 1968; 24: 255–66, and: Cassia occidentals, étude chimique. Ann. pharm. Fr. 26 (11), 673–80
   Google Scholar
• Anton R., Duquénois P. L'emploi des cassias dans les pays tropicaux et subtropicaux, examiné d'après quelques uns des constituants chimiques. Plant. Med. Phytothér. 1968; 2: 255–268
   Google Scholar
• Currie A. O., Timell T. E. Constitution of a methylglucuronoxylan from kapok (Ceiba pentandra). Can. J. Chem. 1959; 37: 922–59
   Web of Science ®Google Scholar
• Johne S., Groeger D. Alkaloide in Linariasorten. Pharmazie 1968; 35–36, 1968
   Google Scholar
• Henry T. A. The Plant Alkaloids, 4th Ed. Churchill, London 1949; 328
   Google Scholar
• Panizzi L., Scarpati M. L. Constitution of cynarine, the active principle of the artichoke. Nature 1954; 74: 1062
   Google Scholar
• Masquelier J., Michaud J. Glycosides de l'artichaut. Bull. Soc. pharm. Bordeaux 1958; 95: 65, ibid. 96, 103 and 97, 77
   Google Scholar
• Suchy M., et al. On Terpenes. CVI. On hydrogenation products of cynaropicrin the bitter principle of artichoke. Collect. Czech. Chem. Comm. 1960; 25: 507–514; 2777
   Google Scholar
• Atherinos A. E., et al. Chemical investigation of Cynara scolymus L. The steroids of the receptacle leaves. J. Chem. Soc. 1962; 1700, 1962
   Web of Science ®Google Scholar
• Michaud J. Contribution à l'étude chimique et analytique de l'artichaut. 1964, These Bordeaux
   Google Scholar
• Nichiforesco E. Sur la composition des dérivés cafeylquiniques des feuilles d'artichaut. Plant. Med. Phytother. 1970; 4: 56–62, and NICHIFORESCO E. and V. COUCOU 1966. Ann. Pharm. Fr. 24, 121–32, 451–56
   Google Scholar
• Boukef K., Balancard C., Susplugas P., Bernard P. Etude d'un heteroside phenolique isolé des feuilles d'Eucalyptus globulus Labill. Pl. Med. et Phytother. 1976; X(2)119–127
   Google Scholar
• Plouvier V. Nouvelles recherches sur… le dulcitol des Celastracées et des Brexia. C. R. Acad. Sci. 1948–49; 227: 85, 1956 228, 1886 and 242, 1645
   Google Scholar
• Elgamal M. H. A., Fayez M. B. E., Snatzke G. Liquoric acid, a new triterpenoid from the roots of Glycyrrhiza glabra L. Tetrahedron Lett. 1965; 21: 2109–15
   Google Scholar
• Hulle van. Rhamnoliquiritin a new flavonone glycoside from the roots of Glycyrrhiza glabra var. typica. Pharm. Tydschr. Belg. 1968; 45(7)137–45, Chem. Abstr. 1969, 106822e
   Google Scholar
• Rydon H. N. A note on the structure of the lupine alkaloids. J. Chem. Soc. 1936, 1936
   Google Scholar
• Clemo G. R., Metcalfe T. P., Raper R. Lupine alkaloids. XI. J. Chem. Soc. 1936; 1429–31, 1936
   Google Scholar
• Winterfeld K., Hoffman E. Alkaloids of the lupins XII. Behaviour of lupinine in the Grignard reaction, Arch. Pharm. 1937; 275: 5–27
   Google Scholar
• Hoffmann E, Holschneider F. W., Winterfeld K. Alkaloids of the lupins. Arch. Pharm. 1937; 275: 65–66
   Google Scholar
• Nottbohm F. E., Mayer Fr. Determination of the bitter substance in blue lupins. Landwirtsch. Jahrb. 1937; 84: 335–48, chem. Abstr. 31, 56719
   Google Scholar
• Blasedale W. C. On ceroptene a new organic compound in Gymnogramma triangularis. J. Amer. Chem. Soc. 1903; 25: 1141
   Google Scholar
• Nilson M. Chalcone from Ceroptis triangularis. Acta Chem. Scand. 1959; 13: 750
   Google Scholar
• Jardon. 1942, Olea europea L. Thèse Pharm. Lyon 1943. in PARIS (2)
   Google Scholar
• Bočkova H., et al. Inhaltstoffe des Ölbaumes (Olea europea L.) Collect. Czech. Chem. Comm. 1964; 29: 1484
   Google Scholar
• Mechoulan R., Danieli N. The structure and synthesis of oleuropeic acid. Tetrahedron Lett. 1962; 709, 1962
   Web of Science ®Google Scholar
• Dar Ikram M. S. M., Fakouki T. Pharmacology of Quercus infectoria. J. Pharm. Sc. 1976; 65: 1791–1794
   PubMed Web of Science ®Google Scholar
• Bylsma J. A review of the investigations on hypotensive substances from the leaves of the olive tree, Olea europea. Pharm. Weekblad 1961; 96: 417–434
   PubMedGoogle Scholar
• Panizzi L., Scarpati M. L., et al. Costituzione della europeina glucoside amaro e ad azione ipotensiva dell' olivo. Gazz. Chim. ital. 1965–1966; 95: 1279–92, and: 6–0-Oleuro-peoylsucrose from Olea europea Tetrahedron Lett. 1966, 5673–74
   Google Scholar
• Villa Sobre O. la pretendida accion antidiabetica del sarandi bianco (Phyllanthus sellowianus Müll.). Rev. Med. Rosario, 30: 921–30
   Google Scholar
• Krishnamurti G. V., Seshadri T. R. Bitter principle of Phyllanthus niruri L. Proc. Indian Ac. Sci. 1946; 357, 1946 Chem. Abstr. 1947, 2712
   Google Scholar
• Rouffiac R., Parello J. Étude chimique des alcaloides de Phyllanthus niruri L. Présence de l'antipode optique de la norsecurinine. Plant. Med. Phytother. 1969; 3: 220
   Google Scholar
• Stanislas E., Rouffiac R., Foyard J. J. Constituants de Phyllanthus niruri. Plant. Med. Phytother. 1967; 1(2–3)13–141
   Google Scholar
• Nara F. K., Gleye J., Lavergne de Cewal E., Stanislas E. Flavonoides de Phyllanthus niruri L, et P. spp. Pl. Med. et Phytother. 1977; XI(2)82–86, 1977
   Google Scholar
• Rosenth Aler L. Ueber die Rinde von Pithecolobium bigeminum Mart. Z. Österr. Apoth. 1906; 44: 147–148
   Google Scholar
• Krall L. P. The oral hypoglycaemic agents. JOSLIN: Diabetes mellitus. Ed. Lea and Febinger. 1971
   Google Scholar
• Fortier G. Les propriétés antidiabétiques de Rhus typhina, le vinaigrier. Laval Med. 1949; 14: 477
   PubMedGoogle Scholar
• Guseinov Ya. D., Yuzbashinskaya P. A. Effect of a sumac extract on normal carbohydrate metabolism and alloxan-induced diabetes in rabbits. Farmakol. Toksikol. (Moscow) 1970; 33: 593–94, Chem. Abstr. 74, 30683j
   PubMedGoogle Scholar
• Montolivo G. Sull 'azione ipoglicemmizante della Rosa canina Riforma med. Napoli 1939; 55: 527–532
   Google Scholar
• Delia. Una nuova droga ipoglicemmizante, la salvia. Clin. Med. Ital. 1938; 69: 315–338
   Google Scholar
• Brieskorn C. H. Active ingredients of Salvia officinalis Bactericidal activity of oil of sage. Arch. Pharm. 1950; 283: 33–35, and 1949. Components of sage leaves. Apoth. Ztg 61, 82
   Google Scholar
• Brieskorn C. H. Diterpenoide Labiaten Bitterstoffe. Pharm. Acta Helv. 1966; 41: 343–345
   PubMedGoogle Scholar
• Oliver B. Medicinal Plants in Nigeria. Ed. Nigerian Coll. Arts, Sci. Technol. Ibadan 1960
   Google Scholar
• Jayawardene S. F., Koch A. E. C. Effect of Torenia asiatica on blood- and urine- sugar in diabetes mellitus. Prelim. Publ., J. Ceylon Brit. Med. Ass. 1941; 38, 1941
   Google Scholar
• Mirsky I. A., Diengott D. Hypoglycemic action of 3-indolacetic acid by mouth in patients with diabetes mellitus. Proc. Soc. Exp. Biol. Med. 1956; 93: 109–10
   PubMed Web of Science ®Google Scholar
• Mirsky I. A. Insulinase, Insulinase-inhibitors and Diabetes mellitus, Recent progress in Hormone Research. Proc. Laurentian Horm. Conference 1956–57. 1956–57, 1956–57; 429–471, 13
   Google Scholar
• Mirsky I. A., Perisutti G., Jinks R. The hypoglycemic action of metabolic derivatives of 1-tryptophan by mouth. Endocrinology 1957; 60: 318–324
   PubMed Web of Science ®Google Scholar
• Ingle D. J. Effect of aspirin upon glycosuria of the partially depancreatized rat. Proc. Soc. Exp. Biol. Med. 1950; 75: 673–74
   PubMed Web of Science ®Google Scholar
• Mayer J. Chromium in medicine. Postgrad. Med. 1971; 49(1)235–36, De Novodok, 1971 Review 71–0570
   PubMedGoogle Scholar
• Wacker W. E. C., Vallee B. L. Chromium ribonucleoprotein from bovine liver. Nature 1959; 184: 1390, and: Nucleic acid and metals. Chromium, manganese, nickel, iron and other metals in ribonucleic acid from diverse biological sources. J. Biol. Chem. 234, 3257–62
   Web of Science ®Google Scholar
• Mazia D. The particulate organization of the chromosome. Proc. Nat. Acad. Sci. USA 1954; 40(6)521
   PubMed Web of Science ®Google Scholar
• Gustavson. A novel type of metal-protein compound. Nature 1958; 182: 1125
   Web of Science ®Google Scholar
• Naismith W. E. F. Arch. Bioch. Biophys. 1958; 73: 255
   Google Scholar
• Heslot H. Le mécanisme moléculaire de la mutagénèse et la nature des mutations. Ann. Amélior. Plant. 1965; 15(2)11–157
   Google Scholar
• Naono S., Gros F. Effects d'un analogue de base nucleique sur la biosynthese des proteines bactériennes. Changement de la composition globale des proteines. C.R. Acad. Sci. Ser. D. 1960; 250: 3527–29
   PubMedGoogle Scholar
• Doumergues R. La destinée de la cellule mutée, conséquences dans les plantes à multiplication végétative et dans le cas à reproduction sexuée. Eucarpia, 3e Congr. Ass. Europ. Amelior. Plant. 1962; 115–19, 1962
   Google Scholar
• Wacker W. E. C. Metalloenzymes. Fed. Proc. Amer. Soc. Exp. Biol. 1970; 29(4)1462–68
   PubMedGoogle Scholar
• Vegni Talluri M., Guiggani V. Action of beryllium ions on primary cultures of swine cells. Caryologica 1968; 355–367, 1968
   Web of Science ®Google Scholar
• Sizer L. W. Oxidation of proteins by tyrosinase and peroxidase. FORD F. F. Advances in Enzymology. Interscience Publishers Inc, New York 1953; 129–159
   Google Scholar
• Chkolnik M. J. Variations morphologiques des plantes, acides nucleiques et synthèses protéiques. Botanicesky Zurnal 1966; 51: 1255–77
   Google Scholar
• Randle P. J., Garland P. B., Hales C. N., Newsholme A. E. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785–789
   PubMed Web of Science ®Google Scholar
• Burkhard M., Hormonsky H. G., Boehli E. Mechanism of prostaglandin E induced Hyperglycemia. Z. Ges. Exp. Med. 1968; 148(2)99–107
   PubMedGoogle Scholar
• Freinkel N., Cohen A. K., Sandler R., Arky R. A. Alcohol hypoglycemia 873–886. J. OSTMAN. Diabetes. Excerpta Med. Found, Amsterdam 1969
   Google Scholar
• Mahler R. J., Szabo O. Postulated mechanism for the insulin synergistic and insulin antagonistic action of growth hormone, Int. Symp. 1968. Ed. 1970
   Google Scholar
• Naylor J. M., Simpson G. M. Dormancy studies in the seed of Avena saliva and gibberellin-sensitive inhibitory mechanism in the embryo. Can. J. Bot. 1961; 39: 281
   Google Scholar
• Le Vine R. Summary on mode of action in “Tolbutamide after 10 years”. 1967, Proc. Brook Lodge Symp., Michigan
   Google Scholar
• Czyzyk A., Ponikowska I., et al. Effect of biguanide derivatives on the intestinal absorption of glucose. Excerpta Med. Int. Congr. Ser. 1967; 140, (Stockholm) no. 95
   Google Scholar
• Zor U., Mishinsky J., Sulman F. G. The hypoglycemic effect of mebazine (Actomol) and its mechanism. Biochem. Pharmacol. 1965; 14: 1059–64
   PubMedGoogle Scholar
• Zor U., Locker D., Schleider M., Sulman F. G. Effect of a monoamine oxidase inhibitor (mebazine) on brain glucose-6-phosphate dehydrogenase activity. Eur. J. Pharmacol. 1967; 2: 193–196
   PubMed Web of Science ®Google Scholar
• Ben-David M., Menczel E., Sulman F. G. The hypoglycaemic effect of azacyclonol and its mechanism. Arch. Int. Pharmacodyn. Thér. 1963; 145(3–4)309–320
   PubMedGoogle Scholar
• Tjoe Tjwan Oen, Puckinger H., Wacker A. Vergleichende Untersuchungen über die Wirkung oraler Antidiabetika an isolierten Langerhanschen Inseln der Ratte. Hoppe Seyler'Z. Physiol. Chem. 1970; 351: 313–19
   PubMedGoogle Scholar
• Theret C. Ultrastructural changes produced by hypoglycaemic sulfonamides. OSTMAN J. Diabetes. Excerpta Med. Found, Amsterdam 1969; 67–91
   Google Scholar
• Loubatieres A. Value of oral antidiabetic medication. Hoppe Seyler'Z. Physiol. Chem. 1969; 717
   PubMedGoogle Scholar
• Chatelet L. R. de, MacDonald H. Inhibition of hepatic protein biosynthesis by various oral hypoglycaemic agents. Site of action. J. Biochem. Pharmacol. 1969; 18: 595–602
   PubMed Web of Science ®Google Scholar